Immunovirotherapy: The role of antibody based therapeutics combination with oncolytic viruses

Despite the fact that the new drugs and targeted therapies have been approved for cancer therapy during the past 30 years, the majority of cancer types are still remain challenging to be treated. Due to the tumor heterogeneity, immune system evasion and the complex interaction between the tumor micr...

Descripción completa

Detalles Bibliográficos
Autores principales: Jafari, Mahdie, Kadkhodazadeh, Maryam, Shapourabadi, Mina Bahrololoumi, Goradel, Nasser Hashemi, Shokrgozar, Mohammad Ali, Arashkia, Arash, Abdoli, Shahriyar, Sharifzadeh, Zahra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9608759/
https://www.ncbi.nlm.nih.gov/pubmed/36311790
http://dx.doi.org/10.3389/fimmu.2022.1012806

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9608759/
https://www.ncbi.nlm.nih.gov/pubmed/36311790
http://dx.doi.org/10.3389/fimmu.2022.1012806

Ejemplares similares